Cargando…

284. Evaluation of Oral Step-Down Therapy for Enterobacteriaceae Bloodstream Infection

BACKGROUND: Oral antibiotic stepdown therapy for Gram-negative (GN) bloodstream infection (BSI) appears to be a safe option, though high bioavailability drugs like fluoroquinolones (FQ) and trimethoprim-sulfamethoxazole are often recommended without clear evidence demonstrating superiority. Due to i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Utley, Sara, Bouknight, Dawn, Patel, Radha, Stock, Kent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778293/ http://dx.doi.org/10.1093/ofid/ofaa439.328

Ejemplares similares

998. Challenging Penicillin Allergies: Pharmacist led program in a community hospital
por: Patel, Radha, et al.
Publicado: (2019)

124. Impact of Levofloxacin MIC on Outcomes with Levofloxacin Step-down Therapy in Enterobacteriaceae Bloodstream Infections
por: White, Melissa, et al.
Publicado: (2019)

191. Oral Antibiotic Step-Down Therapy for Non-Staphylococcal Gram-Positive Bloodstream Infections
por: Gandhi, Kelvin, et al.
Publicado: (2021)

205. Evaluating the Time to Oral Step-Down Therapy for Gram-Negative Bloodstream Infections Associated with a Genitourinary Source
por: Mulvey, Nicole, et al.
Publicado: (2021)

296. IV-to-PO Antibiotic Step-down Therapy for Treatment of Uncomplicated Streptococcal Bloodstream Infections
por: Ramos-Otero, Gerardo P, et al.
Publicado: (2020)

166. Comparison of Oral Fluoroquinolones to Alternative Oral Agents for Definitive Step-Down Therapy in Gram-Negative Bloodstream Infections
por: Cho, Christian Y, et al.
Publicado: (2019)

Impact of Multidrug-resistant Enterobacteriaceae Bloodstream Infections in Children
por: Aizawa, Yuta, et al.
Publicado: (2017)

198. Evaluation of Oral Step-down versus Continued Intravenous Antimicrobial Therapy in Immunocompromised Patients Hospitalized with Gram-Negative Bacteremia
por: Savage, Heather, et al.
Publicado: (2021)

55. Impact of Testing Methodology and Reporting on Time to Preferred Antibiotic Therapy in Extended Spectrum Beta-Lactamase producing Enterobacteriaceae (ESBL-E) Bloodstream Infections
por: Bui, Hanh, et al.
Publicado: (2021)

1811. Minimizing Time to Optimal Therapy for Enterobacteriaceae Bloodstream Infections: Is Organism Identification Enough?
por: Cwengros, Laura N, et al.
Publicado: (2018)

165. Comparative Effectiveness of Oral Fluoroquinolones vs. β-Lactams for the Treatment of Patients with Enterobacteriaceae Bloodstream Infections
por: Bjork, Lauren, et al.
Publicado: (2019)

159. Comparing Clinical Cure and Patient Outcomes Between Intravenous Therapy and Intravenous (IV)-to-Oral (PO) Step-down Therapy for Treatment of Gram-Negative Bloodstream Infections
por: Williams, Kelsey, et al.
Publicado: (2019)

210. Step-down from IV to oral therapy in patients with bacteremia due to Enterobacteriaceae: fluoroquinolones (FQ) vs. ß-lactams (BL) or trimethoprim-sulfamethoxazole (TMP-SMX)
por: Meng, Lina, et al.
Publicado: (2019)

Evaluation of step-down oral antibiotic therapy for uncomplicated streptococcal bloodstream infections on clinical outcomes
por: Kang, Amy, et al.
Publicado: (2022)

222. Oral Step-Down Therapy for Uncomplicated Enterococcus Bacteremia
por: Ni, Jessica, et al.
Publicado: (2023)

122. Evaluation of Early Clinical Failure Criteria in Patients with Enterococcus Species Bloodstream Infection
por: Powers, Caroline, et al.
Publicado: (2019)

1689. Oral Beta-lactam Step Down in Bacteremic E. coli Urinary Tract Infections
por: Saad, Stephan, et al.
Publicado: (2020)

271. Clinical Outcomes Treating Gram-Negative Bacteremia with Oral Beta-Lactams vs. Trimethoprim-Sulfamethoxazole or Fluoroquinolone Step-Down Therapy
por: Sinclair, Emily, et al.
Publicado: (2020)

1113. Oral Tebipenem as Step-Down Therapy Following Intravenous Ertapenem in a 7-day Hollow-Fiber In Vitro Infection Model
por: VanScoy, Brian D, et al.
Publicado: (2021)

277. Comparison of Oral Beta-Lactams and Fluoroquinolones for Step-Down in Uncomplicated Enterobacterales Blood Stream Infections
por: Ngo, Nichol, et al.
Publicado: (2020)

284. Antibiotic Prescribing Trends in Hospitalized Influenza Versus COVID-19 Patients at a Community-Based Health System
por: Martinez, Aileen, et al.
Publicado: (2021)

289. Impact of Clinician Specialty on the Use of Oral Antibiotic Therapy for Definitive Treatment of Uncomplicated Bloodstream Infections
por: Marcelin, Jasmine R, et al.
Publicado: (2020)

141. Evaluating Cefepime And Alternative Beta-lactams For The Treatment Of Serratia marcescens Blood Stream Infections
por: Vicente-Lopez, Natcha, et al.
Publicado: (2022)

1037. Effect of Oral Step-Down Therapy on Readmission Rates in Escherichia coli Bacteremia
por: Sessa, Julia, et al.
Publicado: (2018)

1598. Oral Step Down Therapy With Levofloxacin for Low-Risk Febrile Neutropenia in Children
por: Mehra, Sonia, et al.
Publicado: (2018)

965. The Efficacy of Oral Β-lactam Antibiotics as Step-down Therapy for Acute Pyelonephritis
por: Hobbs, Athena L V, et al.
Publicado: (2019)

663. Improved Detection of ESBL and AmpC Beta-Lactamase Producing Isolates of Enterobacteriaceae in Pediatric Patients with Bloodstream Infections Using Combined Genotypic and Phenotypic Antimicrobial Susceptibility Testing
por: Khalil, Nadim, et al.
Publicado: (2020)

Mortality Impact of CLSI Carbapenem Breakpoint Changes in Enterobacteriaceae Bloodstream Infections: a Patient-level Analysis of Published Data
por: O’Donnell, J Nicholas, et al.
Publicado: (2017)

AB284. SPR-11 What’s wrong with underactive bladder patients?
por: Smith, Phillip P., et al.
Publicado: (2016)

P39 Bloodstream infections (BSI) in tertiary ICU—an update!
por: Patel, Veer M., et al.
Publicado: (2022)

1022. Is it Time to Re-Evaluate Oral Β-Lactam Antibiotics for Step-Down Therapy of Uncomplicated Gram-Negative Bacteremia?
por: McAlister, Michael, et al.
Publicado: (2019)

671. Same Day Identification of Enterobacteriaceae Directly from Urine Samples
por: Kon, Shelley E, et al.
Publicado: (2020)

189. Outcomes of High-dose Oral Beta-lactam Step-down Therapy Compared to Alternative Oral Therapy for Bacteremic Urinary Tract Infections
por: Geyer, Abigail, et al.
Publicado: (2023)

Oral Fluoroquinolone or Trimethoprim-Sulfamethoxazole vs ß-Lactams as Step-Down Therapy for Enterobacteriaceae Bacteremia: Systematic Review and Meta-analysis
por: Punjabi, Chitra, et al.
Publicado: (2019)

1672. Eligibility and Outcomes of Conversion to Oral (PO) Therapy in Patients Hospitalized with Enterobacteriaceae (ENT) Urinary Tract Infection (UTI) in the United States (US): A Multicenter Analysis
por: Melnick, David, et al.
Publicado: (2020)

1447. Emergence of Avibactam Resistance in Multidrug-Resistant Enterobacteriaceae
por: Brennan-Krohn, Thea, et al.
Publicado: (2020)

216. Step-down Therapy With Oral Fluoroquinolones vs. Oral β-Lactams for Hospitalized Adult Patients with Community-Acquired Pneumonia: A Multi-Hospital Cohort Study
por: Petty, Lindsay, et al.
Publicado: (2018)

284. Post-Acute Sequelae of COVID-19 Two Years After Acute Infection
por: Logue, Jennifer, et al.
Publicado: (2022)

186. Evaluating Clinical Outcomes for Treatment of Staphylococcal Bloodstream Infection in Patients with Febrile Neutropenia
por: Aleissa, Muneerah M, et al.
Publicado: (2021)

DIRAC (P284)
por: Gravela, B
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_4j0o9a1q3nkif02cpsevrefu9a